Management specificities of congenital laryngeal stenosis
Marion Blanchard(Hôpital Necker-Enfants Malades), E.N. Garabédian(Hôpital Necker-Enfants Malades), Fergal Glynn(Hôpital Necker-Enfants Malades), J. Blancal(Hôpital Lariboisière), Nicolas Leboulanger(Hôpital Necker-Enfants Malades), Françoise Denoyelle(Hôpital Necker-Enfants Malades), Briac Thierry(Hôpital Necker-Enfants Malades)
Cited by 39
Related Papers
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|558
Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
|International Journal of Pediatric Otorhinolaryngology|2009|235
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
|British Journal of Haematology|2016|130
A Case of Respiratory Depression in a Child With Ultrarapid CYP2D6 Metabolism After Tramadol
|PEDIATRICS|2015|113
Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience
|International Journal of Pediatric Otorhinolaryngology|2010|110